Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Expert Opinion on Biological Therapy
|
January 31, 2012
Obinutuzumab for the treatment of lymphoproliferative disorders
Carolyn Owen, Douglas A Stewart
Expert Opinion on Biological Therapy
|
May 24, 2017
Targeting non-Hodgkin lymphoma with blinatumomab
Sheilagh Sanders, Douglas A Stewart
Therapeutic Advances in Hematology
|
August 20, 2015
Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
Carolyn J Owen, Douglas A Stewart
Expert Opinion on Biological Therapy
|
May 27, 2014
Obinutuzumab for B-cell malignancies
Carolyn J Owen, Douglas A Stewart
Leukemia & Lymphoma
|
June 30, 2009
pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation
Douglas A Stewart, Nizar Bahlis, Adnan Mansoor
Expert Opinion on Pharmacotherapy
|
March 12, 2021
Novel synthetic drugs for the treatment of non-Hodgkin lymphoma
Farheen Manji, Robert Puckrin, Douglas A Stewart
Transplantation and Cellular Therapy
|
February 5, 2022
Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis
Robert Puckrin, Douglas A Stewart, Mona Shafey
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2009
Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma
Douglas A Stewart, Clayton Smith, Ron MacFarland, et al.
Leukemia & Lymphoma
|
April 23, 2022
Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant
Robert Puckrin, Neil Chua, Mona Shafey, et al.
Leukemia & Lymphoma
|
August 3, 2002
ALK-positive anaplastic large T-cell lymphoma preceded by Epstein-Barr virus infection complicated by development of an aorto-esophageal fistula
Sean M Bagshaw, Trudy Crabtree, Francis Green, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Expert Opinion on Biological Therapy
|
January 31, 2012
Obinutuzumab for the treatment of lymphoproliferative disorders
Carolyn Owen, Douglas A Stewart
Expert Opinion on Biological Therapy
|
May 24, 2017
Targeting non-Hodgkin lymphoma with blinatumomab
Sheilagh Sanders, Douglas A Stewart
Therapeutic Advances in Hematology
|
August 20, 2015
Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
Carolyn J Owen, Douglas A Stewart
Expert Opinion on Biological Therapy
|
May 27, 2014
Obinutuzumab for B-cell malignancies
Carolyn J Owen, Douglas A Stewart
Leukemia & Lymphoma
|
June 30, 2009
pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation
Douglas A Stewart, Nizar Bahlis, Adnan Mansoor
Expert Opinion on Pharmacotherapy
|
March 12, 2021
Novel synthetic drugs for the treatment of non-Hodgkin lymphoma
Farheen Manji, Robert Puckrin, Douglas A Stewart
Transplantation and Cellular Therapy
|
February 5, 2022
Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis
Robert Puckrin, Douglas A Stewart, Mona Shafey
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2009
Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma
Douglas A Stewart, Clayton Smith, Ron MacFarland, et al.
Leukemia & Lymphoma
|
April 23, 2022
Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant
Robert Puckrin, Neil Chua, Mona Shafey, et al.
Leukemia & Lymphoma
|
August 3, 2002
ALK-positive anaplastic large T-cell lymphoma preceded by Epstein-Barr virus infection complicated by development of an aorto-esophageal fistula
Sean M Bagshaw, Trudy Crabtree, Francis Green, et al.
Page
of 7